Oxidative lipid modification of nicastrin enhances amyloidogenic γ‐secretase activity in Alzheimer’s disease
Open Access
- 10 March 2012
- journal article
- Published by Wiley in Aging Cell
- Vol. 11 (4) , 559-568
Abstract
Summary: The cause of elevated level of amyloid β‐peptide (Aβ42) in common late‐onset sporadic [Alzheimer’s disease (AD)] has not been established. Here, we show that the membrane lipid peroxidation product 4‐hydroxynonenal (HNE) is associated with amyloid and neurodegenerative pathologies in AD and that it enhances γ‐secretase activity and Aβ42 production in neurons. The γ‐secretase substrate receptor, nicastrin, was found to be modified by HNE in cultured neurons and in brain specimens from patients with AD, in which HNE–nicastrin levels were found to be correlated with increased γ‐secretase activity and Aβ plaque burden. Furthermore, HNE modification of nicastrin enhanced its binding to the γ‐secretase substrate, amyloid precursor protein (APP) C99. In addition, the stimulation of γ‐secretase activity and Aβ42 production by HNE were blocked by an HNE‐scavenging histidine analog in a 3xTgAD mouse model of AD. These findings suggest a specific molecular mechanism by which oxidative stress increases Aβ42 production in AD and identify HNE as a novel therapeutic target upstream of the γ‐secretase cleavage of APP.Keywords
This publication has 46 references indexed in Scilit:
- Oxidative stress in Alzheimer disease: A possibility for preventionNeuropharmacology, 2010
- Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's diseaseNeurobiology of Aging, 2010
- Analysis of the γ-secretase interactome and validation of its association with tetraspanin-enriched microdomainsNature Cell Biology, 2009
- Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesisActa Neuropathologica, 2009
- Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehydeQJM: An International Journal of Medicine, 2001
- Oxidative Damage Is the Earliest Event in Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 2001
- Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer AmyloidosisJournal of Neuroscience, 2001
- Pro‐apoptotic function of calsenilin/DREAM/KChIP3The FASEB Journal, 2001
- Presenilin 1 is linked with γ-secretase activity in the detergent solubilized stateProceedings of the National Academy of Sciences, 2000
- A Mechanism for the Neuroprotective Effect of Apolipoprotein EJournal of Neurochemistry, 2000